Application no. and date | 21172996.7 (espacenet) (Federated) (European Patent Register), 20161216 | Patent/reg. no. and date | DK/EP 3889145, 20240221 | Publication date | 20211006 | Priority no. and date | US 201562268765 P, 20151217, US 201662353603 P, 20160623 | EP pub. no. and date |
EP 3889145 20211006 | Effective date | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | Applicant ref. no. | V473383DK00 | Inventor | Sherer, Brian,
Billerica, MA 01821-3936, US, Brugger, Nadia,
Burlington, MA 01803, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4709 (2006.01) , A61P 17/06 (2006.01) , A61P 19/00 (2006.01) , A61P 25/00 (2006.01) , A61P 29/00 (2006.01) , A61P 3/10 (2006.01) , A61P 37/00 (2006.01) , A61P 9/10 (2006.01) , C07D 401/04 (2006.01) | Title | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|